Latest news with #WHOGuidelines
Yahoo
a day ago
- Health
- Yahoo
'Birmingham kids struggling to breathe toxic air in city's schools'
Children in Birmingham are coming to school tired, struggling to breathe or even missing school altogether because of toxic air, a teacher has revealed. A city school teacher, who worked in Perry Barr and Lozells, opened up on his first hand-experience, branding air pollution a "crisis that's harming our health." Ibrahim Ali spoke of having to 'step back' from his career in teaching in a new Health Equals campaign urging the Government to prioritise action tackling air pollution. Read more: Birmingham killer who stabbed neighbour to death dies in hospice with 'family by his side' Alarming new figures from its report this week revealed every school - all 506 - in Birmingham is failing World Health Organization (WHO) guidelines on air pollution - with thousands of kids exposed to double the amount stipulated in guidelines. Areas like Ladywood, Erdington and Perry Barr are among the worst affected in Britain, its data showed. School teacher Mr Ali said: 'In parts of Birmingham like Perry Barr and Lozells, air pollution isn't just a nuisance - it's a crisis that's harming our health. "I've seen the impact in my own body, my children's wellbeing, and the classroom every day. Kids are tired, struggling to breathe, missing school because the air around them is toxic. "I had to step back from a career I love due to Crohn's Disease, which research shows can be aggravated by prolonged exposure to pollution. "Birmingham is one of the worst-hit areas in the country - and yet this silent threat continues to go unchecked. That's why I'm supporting the Health Equals campaign. Clean air must be a right, not a privilege: because where you live should never determine how long or how well you live.' The new report shows 12 million children live in neighbourhoods where pollution breached WHO guidelines. Air pollution is now the second leading risk factor for death in children under five in the UK, a recent report by the Royal College of Paediatrics and Child Health (RCPCH) also found. Across the UK toxic air, alongside other issues including poor income, unstable jobs and unsafe homes, is contributing to lives being cut short by up to 16 years, the Health Equals campaign revealed. Analysis shows that a staggering 90 per cent of the British population live in areas that exceed WHO guidelines, however only 41 per cent of people in the West Midlands are aware the air where they live is damaging their health. Health Equals is a coalition of 85 organisations across different sectors, including Mind, the British Red Cross, Legal and General, the Local Government Association, Citizens Advice, Global Action Plan, Crisis, The Wildlife Trusts and the Joseph Rowntree Foundation. 'Our health is shaped by the world around us – from the air we breathe, to the homes we live in, the money in our pockets and the work we do – these are the building blocks of health," said Paul McDonald, Chief Campaigns Officer at Health Equals. "Clean air isn't just an environmental issue — it's a clear example of health inequality in the UK. "While some children breathe safely, many grow up in areas where toxic air damages their lungs before they even reach school. Clean air is just one part of the problem, and that's why we're calling for a cross-government health inequalities strategy to Make Health Equal.' BirminghamLive has contacted Birmingham City Council for a comment. Have you been affected by this. We would like to hear from you. You can contact us by emailing us on
Associated Press
25-03-2025
- Health
- Associated Press
PHARMANUTRA S.P.A.: SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE 'WORLD HEALTH ORGANISATION'
THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES PISA, Italy, March 25, 2025 /CNW/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces that oral Sucrosomial® Iron, the innovative formulation designed and patented by PharmaNutra that forms the basis of SiderAL® products, has been included in the recent World Health Organisation (WHO) Guidelines entitled 'Guidance on implementing patient blood management to improve global blood health status'. The Guidance, which focuses on the efficiency and improvement of patient management in order to reduce the use of blood transfusions, is the result of extensive collaboration between international experts in multidisciplinary fields dedicated to improving patient outcomes, safety and quality of care. It is therefore also a useful practical guide to address the global problem of iron deficiency and anaemia, blood loss and coagulopathies with bleeding. In particular, referring to sideropenia in cardiovascular disease and diabetes, within the WHO Guidelines Sucrosomal® Iron is the only oral iron mentioned and recognised. Evidence of extraordinary relevance for Sucrosomial® Technology, PharmaNutra Group's innovative delivery system, capable of protecting micronutrient molecules such as iron, increasing their absorption and improving their gastrointestinal tolerability. An achievement of great impact, considering that iron deficiency remains the most widespread nutritional deficiency in the world today. The World Health Organisation document points out that anaemia is a common occurrence in people with both cardiovascular disease and diabetes. In fact, it is estimated that at least 170 million people worldwide with such comorbidities have anaemia. Germano Tarantino, Chief Scientific Officer of PharmaNutra S.p.A., states: 'The reference to Sucrosomial® Iron within the World Health Organisation Guidelines is an important recognition of the value of our patent, now of worldwide relevance, but also for the work carried out by our research and development department in recent years. This evidence gives us further impetus to continue to invest in research to further refine and improve Sucrosomial® Technology, and to ensure increasingly effective solutions both as a means of preventing and counteracting iron deficiency, and as supplementation in all areas where this condition is one of the most frequent complications' PharmaNutra S.p.A. Founded and led by the President Andrea Lacorte and Vice President Roberto Lacorte, PharmaNutra was established in 2003. It develops unique nutritional supplements and innovative nutritional devices, handling the entire production process, from proprietary raw materials to finished product. PharmaNutra is a leader in the production of iron-based nutritional supplements with the SiderAL® brand, where it can claim important Sucrosomial® Technology patents, and is considered one of the top players in the sector of medical devices dedicated to the restoration of joint capacity thanks to the Cetilar® brand, now on the market also with Cetilar® Nutrition, a line of supplements designed for those who practice sport constantly. Over the years the Group - present abroad in over 89 countries - has developed precise strategy for the management and production of intellectual property, founded on the integrated management of all the various elements: proprietary raw materials, patents, brands and clinical evidence.
